Liver Cancer Information Center
Each year in the United States, more than 21,000 people will be diagnosed with primary liver cancer (cancer that began in the liver). To reduce these numbers, researchers continue to explore new approaches to liver cancer prevention.
Progress is also being made in the early detection and treatment of liver cancer. Although long-term survival with liver cancer remains poor, advances in surgery, other liver-directed therapies, and targeted systemic therapies are all contributing to improved outcomes. In addition, advances in supportive care have made liver cancer treatment more tolerable, leading to improved quality of life.
Understanding liver cancer treatment options, the role of different doctors specializing in the treatment of liver cancer, and how and when to access new and innovative liver cancer treatment options available through clinical trials is essential in order to achieve the best outcome from liver cancer treatment.
The Cancer Consultants Liver Cancer Information Center has been designed to help patients understand options for liver cancer prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of liver cancer.
Headline Liver Cancer News 
Sutent® Not Effective for Advanced Liver Cancer
A Phase II clinical trial shows no benefit of Sutent in advanced liver cancer.
Women with Hypothyroidism at Increased Risk of Liver Cancer
Long-term hypothyroidism in women significantly increases the risk of developing...
Incidence of Liver Cancer on the Rise
The incidence of liver cancer in the United States tripled between 1975 and 2005,...
Liver Cancer Tips
Managing a rare cancer One survivor shares her tips for navigating the sometimes...
Sun Safety During Cancer Treatment Shielding your skin from the sun’s potentially harmful ultraviolet rays...
Understanding the Goals of Cancer Treatment with Chemotherapy If you’ve been diagnosed with cancer, your healthcare team may have prescribed...
Liver Cancer Management
Inspiration, Hope & Resources
On Top of the World: Climbing Everest & Beating Cancer Twice Sean Swarner is a master of setting a goal and achieving it. So when he...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Where Kids Can Be Kids… And Cancer Takes a Back Seat Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Liver Cancer Clinical Trials
COGAEPI04C1 – Low Birth Weight & Other Risk Factors for Hepatoblastoma- A Groupwide Protocol
INSTOX-05-024 – Phase II Trial of Gemcitabine and Oxaliplatin (Gem-Ox) with Erlotinib (Tarceva) in the Treatment of Hepatocellular Carcinoma (HCC) in patients with adequate platelets (>100,000/?L)
ZX101-301 – A Phase II Randomized Controlled Study Comparing The Survival of Patients With Unresectable Hepatocellular Carcinoma (HCC) Treated With THYMITAQ To Patients Treated With Doxorubicin
 |
 |
 |
 |
